Report cover image

Global Perfluorocarbon-based Ultrasound Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 195 Pages
SKU # APRC20277587

Description

Summary

According to APO Research, The global Perfluorocarbon-based Ultrasound Contrast Agents market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents include Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Feiruida Medical, Fuman Group, Lizhuo Pharmaceutical and Qi-hui Biopharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Perfluorocarbon-based Ultrasound Contrast Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Perfluorocarbon-based Ultrasound Contrast Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Perfluorocarbon-based Ultrasound Contrast Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Perfluorocarbon-based Ultrasound Contrast Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Perfluorocarbon-based Ultrasound Contrast Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Perfluorocarbon-based Ultrasound Contrast Agents sales, projected growth trends, production technology, application and end-user industry.

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Company

Bracco
GE Healthcare
ImaRx Therapeutics
Lantheus Medical Imaging
Microvascular Therapeutics
Feiruida Medical
Fuman Group
Lizhuo Pharmaceutical
Qi-hui Biopharmaceutical
SUNΛ Med-Engineering
Perfluorocarbon-based Ultrasound Contrast Agents Segment by Type

Perfluorobutane
Perfluoropropane
Sulfur Hexafluoride
Others
Perfluorocarbon-based Ultrasound Contrast Agents Segment by Application

Liver Ultrasonography
Cardiac Ultrasonography
Angiographic Ultrasonography
Others
Perfluorocarbon-based Ultrasound Contrast Agents Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perfluorocarbon-based Ultrasound Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Perfluorocarbon-based Ultrasound Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perfluorocarbon-based Ultrasound Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Perfluorocarbon-based Ultrasound Contrast Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Perfluorocarbon-based Ultrasound Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Perfluorocarbon-based Ultrasound Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Perfluorocarbon-based Ultrasound Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2020 VS 2024 VS 2031
1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Estimates and Forecasts (2020-2031)
1.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Estimates and Forecasts (2020-2031)
1.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
2.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends
2.2 Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers
2.3 Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges
2.4 Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints
3 Perfluorocarbon-based Ultrasound Contrast Agents Market by Manufacturers
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (2020-2025)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (2020-2025)
3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Sales Price by Manufacturers (2020-2025)
3.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers, Product Type & Application
3.7 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market CR5 and HHI
3.8.2 Global Top 5 and 10 Perfluorocarbon-based Ultrasound Contrast Agents Players Market Share by Revenue in 2024
3.8.3 2024 Perfluorocarbon-based Ultrasound Contrast Agents Tier 1, Tier 2, and Tier 3
4 Perfluorocarbon-based Ultrasound Contrast Agents Market by Type
4.1 Perfluorocarbon-based Ultrasound Contrast Agents Type Introduction
4.1.1 Perfluorobutane
4.1.2 Perfluoropropane
4.1.3 Sulfur Hexafluoride
4.1.4 Others
4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type
4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2020-2031)
4.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2020-2031)
4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type
4.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2020-2031)
4.3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2020-2031)
5 Perfluorocarbon-based Ultrasound Contrast Agents Market by Application
5.1 Perfluorocarbon-based Ultrasound Contrast Agents Application Introduction
5.1.1 Liver Ultrasonography
5.1.2 Cardiac Ultrasonography
5.1.3 Angiographic Ultrasonography
5.1.4 Others
5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
5.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2020-2031)
5.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2020-2031)
5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application
5.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2020-2031)
5.3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2020-2031)
6 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
6.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2020-2031)
6.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2020-2025)
6.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
7.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
7.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2020-2025)
7.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2026-2031)
7.1.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031)
7.2.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031)
7.3.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031)
7.4.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Bracco
8.1.1 Bracco Comapny Information
8.1.2 Bracco Business Overview
8.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.1.5 Bracco Recent Developments
8.2 GE Healthcare
8.2.1 GE Healthcare Comapny Information
8.2.2 GE Healthcare Business Overview
8.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.2.5 GE Healthcare Recent Developments
8.3 ImaRx Therapeutics
8.3.1 ImaRx Therapeutics Comapny Information
8.3.2 ImaRx Therapeutics Business Overview
8.3.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.3.5 ImaRx Therapeutics Recent Developments
8.4 Lantheus Medical Imaging
8.4.1 Lantheus Medical Imaging Comapny Information
8.4.2 Lantheus Medical Imaging Business Overview
8.4.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.4.5 Lantheus Medical Imaging Recent Developments
8.5 Microvascular Therapeutics
8.5.1 Microvascular Therapeutics Comapny Information
8.5.2 Microvascular Therapeutics Business Overview
8.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.5.5 Microvascular Therapeutics Recent Developments
8.6 Feiruida Medical
8.6.1 Feiruida Medical Comapny Information
8.6.2 Feiruida Medical Business Overview
8.6.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.6.5 Feiruida Medical Recent Developments
8.7 Fuman Group
8.7.1 Fuman Group Comapny Information
8.7.2 Fuman Group Business Overview
8.7.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.7.5 Fuman Group Recent Developments
8.8 Lizhuo Pharmaceutical
8.8.1 Lizhuo Pharmaceutical Comapny Information
8.8.2 Lizhuo Pharmaceutical Business Overview
8.8.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.8.5 Lizhuo Pharmaceutical Recent Developments
8.9 Qi-hui Biopharmaceutical
8.9.1 Qi-hui Biopharmaceutical Comapny Information
8.9.2 Qi-hui Biopharmaceutical Business Overview
8.9.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.9.5 Qi-hui Biopharmaceutical Recent Developments
8.10 SUNΛ Med-Engineering
8.10.1 SUNΛ Med-Engineering Comapny Information
8.10.2 SUNΛ Med-Engineering Business Overview
8.10.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
8.10.5 SUNΛ Med-Engineering Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Analysis
9.1.1 Perfluorocarbon-based Ultrasound Contrast Agents Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Perfluorocarbon-based Ultrasound Contrast Agents Production Mode & Process
9.2 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
9.2.3 Perfluorocarbon-based Ultrasound Contrast Agents Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.